Then: 2002 IPO 20c
Pros:
1. 1x plastic syringe & a Dream...
cons:
1. 1x plastic syringe & a Dream
2. No signed Agreements with any parties.
Now: 2016 SP 5.3c
Pros:
1. Dual listed Co. on ASX & Nasdaq: One of the biggest trading markets.
2. Ownership of state of the art lab & customized Sigma 6 manufacturing facility in USA.
3. Ownership of IP & specialized proprietary featured WI portfolio.
4. Signed Agreement with 3x Major Pharmas to grant access to Unilife Technology.
5. New management with 100% backing by 2x major creditors (Creditors, who know exactly what is going on).
6. 2x major creditors allowing Co to continue trading.
7. Currently working with major Pharmas in WI customization programs.
8. Relationships with strategic supply chain partners.
9. Industry experienced specialist senior management team.
10. Expected WI commercialization Deals with major Pharmas in the pipeline.
Cons:
1. Money tight short term?
2. Grumpy SHrs
So why is UNS SP only 5.3c and not at 20c plus??
.
UNS Price at posting:
5.5¢ Sentiment: Buy Disclosure: Held
